» Authors » Fiachra Moloney

Fiachra Moloney

Explore the profile of Fiachra Moloney including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 231
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Clifford D, Moloney F, Leahy T, Murray D
BMJ Case Rep . 2022 Apr; 15(4). PMID: 35450878
Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency. We wish to add to the available literature by reporting two brothers with clinical, radiological and immunological features of Roifman...
2.
Balta J, Twomey M, Moloney F, Duggan O, Murphy K, OConnor O, et al.
Anat Histol Embryol . 2018 Nov; 48(1):64-73. PMID: 30450564
Cadaveric material has long been used to teach anatomy and more recently to train students in clinical skills. The aim of this study was to develop a systematic approach to...
3.
Moloney F, James K, Twomey M, Ryan D, Grey T, Downes A, et al.
Emerg Radiol . 2018 Nov; 26(2):169-177. PMID: 30448900
Objectives: Performance of a modified abdominopelvic CT protocol reconstructed using full iterative reconstruction (IR) was assessed for imaging patients presenting with acute abdominal symptoms. Materials And Methods: Fifty-seven patients (17...
4.
OBrien S, Twomey M, Moloney F, Kavanagh R, Carey B, Power D, et al.
J Gastric Cancer . 2018 Oct; 18(3):242-252. PMID: 30276001
Purpose: Surgical resection for gastric adenocarcinoma is associated with significant post-operative morbidity and mortality. The aim of this study was to assess the prognostic significance of sarcopenia in patients undergoing...
5.
Ronan N, Bennett D, Khan K, McCarthy Y, Dahly D, Bourke L, et al.
Lung . 2018 Aug; 196(5):543-552. PMID: 30066212
Background: Pirfenidone is a novel anti-fibrotic agent in idiopathic pulmonary fibrosis with proven clinical benefit. Better human tissue models to demonstrate the immunomodulatory and anti-fibrotic effect of pirfenidone are required....
6.
Moloney F, Twomey M, Fama D, Balta J, James K, Kavanagh R, et al.
J Med Imaging Radiat Oncol . 2018 Apr; 62(5):625-633. PMID: 29656596
Introduction: Cadaveric studies provide a means of safely assessing new technologies and optimizing scanning prior to clinical validation. Reducing radiation exposure in a clinical setting can entail incremental dose reductions...
7.
Twomey M, Fleming H, Moloney F, Murphy K, Crush L, ONeill S, et al.
World J Radiol . 2017 May; 9(4):206-211. PMID: 28529684
Aim: To evaluate the association between C-reactive protein (CRP) and radiological evidence of lower respiratory tract infection (LRTI) in infants. Methods: All patients aged less than 4 years who presented...
8.
McLaughlin P, Moloney F, ONeill S, James K, Crush L, Flanagan O, et al.
J Med Imaging Radiat Oncol . 2017 Feb; 61(3):334-338. PMID: 28156051
Introduction: The authors propose that tablet computers could benefit patients with acute stroke in the remote care setting, where time to and accuracy of CT interpretation greatly influences patient outcome....
9.
Power S, Moloney F, Twomey M, James K, OConnor O, Maher M
World J Radiol . 2017 Jan; 8(12):902-915. PMID: 28070242
Since its introduction in the 1970s, computed tomography (CT) has revolutionized diagnostic decision-making. One of the major concerns associated with the widespread use of CT is the associated increased radiation...
10.
Murphy K, McLaughlin P, Twomey M, Chan V, Moloney F, Fung A, et al.
J Med Imaging Radiat Oncol . 2016 Oct; 61(2):190-196. PMID: 27739229
Introduction: We assess the ability of low-dose hybrid iterative reconstruction (IR) and 'pure' model-based IR (MBIR) images to maintain accurate Hounsfield unit (HU)-determined tissue characterization. Methods: Standard-protocol (SP) and low-dose...